LEAH AMOROSE: Open Payments
NPI 1073172326 · TAYLOR, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$551 in 26 payments from 10 companies in 2025. Trend: 2023 $460 · 2024 $583 · 2025 $551
Food & beverage: $551
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Novo Nordisk Inc | 4 | $89 |
| ABBVIE INC. | 3 | $80 |
| SANOFI-AVENTIS U.S. LLC | 2 | $51 |
| Exact Sciences Corporation | 2 | $43 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
| PFIZER INC. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: VRAYLAR, AIRSUPRA, Ozempic, TZIELD, Cologuard Collection Kit, TRELEGY ELLIPTA, Rybelsus, ZENPEP.
Industry payments across MI — which companies pay providers there.
